Modeling the Cost-Effectiveness of Successive Preventive Oral Medication Trials in Chronic Migraine

被引:0
|
作者
Ney, J. [1 ]
Guirguis, A. [1 ]
Dao, V [2 ]
Sico, J. [1 ]
机构
[1] VA Connecticut Hlth Care Syst, West Haven, CT USA
[2] Minneapolis VA Med Ctr, Minneapolis, MN USA
来源
HEADACHE | 2023年 / 63卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-213
引用
收藏
页码:195 / 196
页数:2
相关论文
共 50 条
  • [31] 10-YEAR COST-EFFECTIVENESS ANALYSES OF FREMANEZUMAB COMPARED TO NO TREATMENT AS A PREVENTIVE TREATMENT IN CHRONIC AND EPISODIC MIGRAINE FOR PATIENTS WITH INADEQUATE RESPONSE TO PRIOR PREVENTIVE TREATMENTS
    Smolen, L.
    Gandhi, S. K.
    Klein, T.
    Thompson, S.
    Cohen, J.
    VALUE IN HEALTH, 2019, 22 : S743 - S743
  • [32] Cost-effectiveness calculations from trials
    Ambrosioni, E
    Costa, FV
    JOURNAL OF HYPERTENSION, 1996, 14 : S47 - S52
  • [33] Cost-effectiveness of Preventive Oral Health Care in Medical Offices for Young Medicaid Enrollees
    Stearns, Sally C.
    Rozier, R. Gary
    Kranz, Ashley M.
    Pahel, Bhavna T.
    Quinonez, Rocio B.
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2012, 166 (10): : 945 - 951
  • [34] MODELING ONLINE COST-EFFECTIVENESS
    MAGSON, MS
    ASLIB PROCEEDINGS, 1980, 32 (01): : 35 - 41
  • [35] Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries
    Hens, Manuel
    Villaverde-Hueso, Ana
    Alonso, Veronica
    Abaitua, Ignacio
    Posada de la Paz, Manuel
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (04): : 433 - 437
  • [36] Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries
    Manuel Hens
    Ana Villaverde-Hueso
    Veronica Alonso
    Ignacio Abaitua
    Manuel Posada de la Paz
    The European Journal of Health Economics, 2014, 15 : 433 - 437
  • [37] A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy
    Wolters, Sharon
    Carpay, Johannes A.
    Pronk, Marja H.
    Zuurbier, Karin W. M.
    Driessen, Maurice T.
    Lyras, Leonidas
    Postma, Maarten J.
    BMC NEUROLOGY, 2024, 24 (01)
  • [38] Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine
    Lofland, JH
    Kim, SS
    Batenhorst, AS
    Johnson, NE
    Chatterton, ML
    Cady, RK
    Kaniecki, R
    Nash, DB
    MAYO CLINIC PROCEEDINGS, 2001, 76 (11) : 1093 - 1101
  • [39] COST-EFFECTIVENESS OF A MEDICATION REFILL REMINDER SYSTEM
    CHRISCHILLES, EA
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (06): : 441 - 441
  • [40] COST-EFFECTIVENESS OF A MEDICATION MANAGEMENT-SYSTEM
    CAMP, T
    LINDMARK, WD
    MILITARY MEDICINE, 1980, 145 (09) : 632 - 636